壮观霉素类似物U-63366、新型大环内酯类抗生素罗红霉素（RU 28965）以及五种喹诺酮衍生物对杜克雷嗜血杆菌的体外活性。
In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
作者信息
Sanson-Le Pors M J, Casin I M, Thebault M C, Arlet G, Perol Y
出版信息
Antimicrob Agents Chemother. 1986 Sep;30(3):512-3. doi: 10.1128/AAC.30.3.512.
Abstract
The in vitro activities of the new spectinomycin analog U-63366, the new macrolide roxithromycin (RU 28965), and five new quinolone derivatives (pefloxacin, rosoxacin, norfloxacin, ofloxacin, and ciprofloxacin) were studied against 23 multiresistant strains of Haemophilus ducreyi (beta-lactamase producers) isolated in Paris and were compared with the activities of tetracycline, minocycline, chloramphenicol, streptomycin, kanamycin, gentamicin, spectinomycin, erythromycin, and nalidixic acid. All strains were uniformly susceptible to the seven new antibiotics tested. Ciprofloxacin had the greatest inhibitory effect in vitro (the MIC for 90% of the strains tested [MIC90] was 0.016 microgram/ml), and U-63366 was the most active aminoglycoside-aminocyclitol antibiotic (MIC90, 0.25 microgram/ml).
摘要
研究了新型壮观霉素类似物U - 63366、新型大环内酯类药物罗红霉素（RU 28965）以及五种新型喹诺酮衍生物（培氟沙星、咯索沙星、诺氟沙星、氧氟沙星和环丙沙星）对在巴黎分离出的23株多重耐药性杜克雷嗜血杆菌（产生β - 内酰胺酶）的体外活性，并与四环素、米诺环素、氯霉素、链霉素、卡那霉素、庆大霉素、壮观霉素、红霉素和萘啶酸的活性进行了比较。所有菌株对所测试的七种新型抗生素均表现出一致的敏感性。环丙沙星在体外具有最大的抑制作用（所测试菌株中90%的最低抑菌浓度[MIC90]为0.016微克/毫升），而U - 63366是活性最高的氨基糖苷 - 氨基环醇类抗生素（MIC90为0.25微克/毫升）。
相似文献
1
In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.壮观霉素类似物U-63366、新型大环内酯类抗生素罗红霉素（RU 28965）以及五种喹诺酮衍生物对杜克雷嗜血杆菌的体外活性。
Antimicrob Agents Chemother. 1986 Sep;30(3):512-3. doi: 10.1128/AAC.30.3.512.
2
In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.壮观霉素类似物U-63366及四种喹诺酮衍生物对淋病奈瑟菌的体外活性
Antimicrob Agents Chemother. 1984 Oct;26(4):608-9. doi: 10.1128/AAC.26.4.608.
3
Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
J Antimicrob Chemother. 1987 Feb;19(2):187-91. doi: 10.1093/jac/19.2.187.
4
The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.
J Antimicrob Chemother. 1985 Aug;16(2):165-8. doi: 10.1093/jac/16.2.165.
5
In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.30株杜克雷嗜血杆菌对包括6种头孢菌素在内的几种抗生素的体外敏感性
J Antimicrob Chemother. 1983 Mar;11(3):271-80. doi: 10.1093/jac/11.3.271.
6
Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.美国杜克雷嗜血杆菌分离株的体外抗菌药敏性与β-内酰胺酶质粒含量之间的相关性
Antimicrob Agents Chemother. 1992 Aug;36(8):1639-43. doi: 10.1128/AAC.36.8.1639.
7
Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.杜克雷嗜血杆菌在体外对壮观霉素的敏感性。
Genitourin Med. 1986 Aug;62(4):251-2. doi: 10.1136/sti.62.4.251.
8
Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.泰国分离的杜克嗜血杆菌的抗菌药敏性及外膜蛋白特性
J Clin Microbiol. 1985 Mar;21(3):442-4. doi: 10.1128/jcm.21.3.442-444.1985.
9
In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.新型大环内酯类抗生素罗红霉素（RU 28965）对流感嗜血杆菌临床分离株的体外活性
Antimicrob Agents Chemother. 1986 May;29(5):921-2. doi: 10.1128/AAC.29.5.921.
10
A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.罗沙米星、红霉素、克林霉素、甲硝唑和奥硝唑对杜克雷嗜血杆菌（包括产β-内酰胺酶菌株）的体外活性比较。
J Antimicrob Chemother. 1979 Nov;5(6):731-4. doi: 10.1093/jac/5.6.731.
引用本文的文献
1
Mild and convenient -formylation protocol in water-containing solvents.在含水溶剂中温和且便捷的甲酰化方法。
Tetrahedron Lett. 2013 Apr 17;54(16):2077-2081. doi: 10.1016/j.tetlet.2013.02.013.
2
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
3
Biotypes, serotypes, and susceptibility to antibiotics of 60 Haemophilus influenzae strains from genitourinary tracts.来自泌尿生殖道的60株流感嗜血杆菌的生物型、血清型及抗生素敏感性
Genitourin Med. 1988 Jun;64(3):185-8. doi: 10.1136/sti.64.3.185.
4
Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.曲古霉素对脆弱拟杆菌及其他拟杆菌属菌种的活性。
Antimicrob Agents Chemother. 1988 Apr;32(4):584-6. doi: 10.1128/AAC.32.4.584.
5
Quinolone antibacterial agents for the treatment of genitourinary tract infections.用于治疗泌尿生殖道感染的喹诺酮类抗菌剂。
Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1111-6. doi: 10.1007/BF01975178.
6
New directions for macrolide antibiotics: structural modifications and in vitro activity.大环内酯类抗生素的新方向：结构修饰与体外活性
Antimicrob Agents Chemother. 1989 Sep;33(9):1413-8. doi: 10.1128/AAC.33.9.1413.
7
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
8
Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.培氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 May;37(5):628-68. doi: 10.2165/00003495-198937050-00003.
9
Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.罗红霉素：抗菌活性、药代动力学特性及临床疗效综述
Drugs. 1989 Jan;37(1):8-41. doi: 10.2165/00003495-198937010-00002.
10
Chancroid and Haemophilus ducreyi.软下疳与杜克雷嗜血杆菌。
Clin Microbiol Rev. 1989 Apr;2(2):137-57. doi: 10.1128/CMR.2.2.137.
本文引用的文献
1
Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.在约翰内斯堡分离出的103株杜克雷嗜血杆菌的抗菌药敏性
Antimicrob Agents Chemother. 1982 Oct;22(4):686-8. doi: 10.1128/AAC.22.4.686.
2
Detection of chloramphenicol acetyltransferase (CAT) activity in a strain of Haemophilus ducreyi.一株杜克雷嗜血杆菌中氯霉素乙酰转移酶（CAT）活性的检测。
Ann Microbiol (Paris). 1982 Sep-Oct;133(2):311-5.
3
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
4
In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.30株杜克雷嗜血杆菌对包括6种头孢菌素在内的几种抗生素的体外敏感性
J Antimicrob Chemother. 1983 Mar;11(3):271-80. doi: 10.1093/jac/11.3.271.
5
The plasmids of Haemophilus ducreyi.杜克雷嗜血杆菌的质粒
J Antimicrob Chemother. 1984 Dec;14(6):561-4.
6
Antimicrobial therapy of chancroid: effectiveness of erythromycin.
J Infect Dis. 1983 Oct;148(4):726-31. doi: 10.1093/infdis/148.4.726.
7
Plasmid-mediated tetracycline resistance in Haemophilus ducreyi.杜克雷嗜血杆菌中质粒介导的四环素耐药性。
Antimicrob Agents Chemother. 1984 Feb;25(2):187-90. doi: 10.1128/AAC.25.2.187.
8
Drug of choice for chancroid.
Lancet. 1983 Jan 15;1(8316):125. doi: 10.1016/s0140-6736(83)91766-x.
9
Streptomycin-resistant Haemophilus ducreyi.
Lancet. 1982 Nov 6;2(8306):1043. doi: 10.1016/s0140-6736(82)90072-1.
10
Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
Lancet. 1982 Sep 4;2(8297):509-11. doi: 10.1016/s0140-6736(82)90597-9.
Zotero 插件